REV-ERB agonist comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-05-24. Numbers and descriptions here follow the published literature rather than marketing material.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.
SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.
SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.
| Property | Value | Notes |
|---|---|---|
| Common name | SR9009 | Also referred to as Stenabolic in non-scientific contexts. |
| Chemical class | Synthetic small molecule | Not a steroid or peptide hormone. |
| Receptor target | REV-ERBα and REV-ERBβ | Nuclear receptor agonist in preclinical studies. |
| Development status | Investigational | No approved human therapeutic indication. |
| Regulatory attention | Prohibited in sport | Listed by anti-doping authorities. |
Analytical identification and purity assessment often use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Liquid chromatography–tandem mass spectrometry is used to detect and quantify SR9009 in biological matrices, including urine and blood, for anti-doping or pharmacokinetic studies. Nuclear magnetic resonance spectroscopy can confirm molecular structure. Stability depends on form and storage: the solid is generally more stable than solutions, and repeated freeze–thaw cycles may degrade samples. Purity is typically reported as a percentage from a certificate of analysis.
Regulatory treatment of SR9009 varies by country and context. It is not approved as a therapeutic drug by agencies such as the United States Food and Drug Administration or the European Medicines Agency. Sports authorities list it as a prohibited substance; the World Anti-Doping Agency classifies it among hormone and metabolic modulators. Legal status for personal possession or sale differs across jurisdictions, and some countries may restrict it under analog or research chemical laws. Buyers who seek verified material often rely on independent laboratory testing because online product labels may not match contents.
Laboratory samples of SR9009 are typically handled as research chemicals rather than pharmaceuticals. Suppliers usually state that the material is for research use only and not for human or veterinary administration. Storage recommendations generally call for a freezer at approximately −20 °C, protection from light, and a desiccated environment. The solid is often described as a white to off-white powder. Solubility is commonly reported in organic solvents such as dimethyl sulfoxide and ethanol, with low solubility in water.
Laboratory samples of SR9009 are typically supplied as a white to off-white powder. The compound dissolves readily in organic solvents such as dimethyl sulfoxide and ethanol, while its solubility in water is low. Because of this solubility profile, researchers often prepare concentrated stock solutions in an organic solvent before diluting them into aqueous assay buffers. Light exposure, moisture, and repeated freeze-thaw cycles can degrade many small molecules, so handling procedures usually aim to minimize these factors. Purity is commonly checked before use.
Storage conditions for research-grade SR9009 generally involve a freezer at approximately minus twenty degrees Celsius, sometimes lower for long-term preservation. Containers should remain tightly closed and protected from light. Desiccants may be used to limit moisture uptake. Solutions are often stored in aliquots to avoid repeated warming and cooling. Stability data for the compound under various conditions are limited, so laboratories typically follow supplier recommendations and verify performance through periodic analytical checks rather than assuming indefinite stability.
In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.
Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.
Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.
== ADLM Annual Scientific Meeting == ADLM holds several scientific conferences each year, the largest of which is the ADLM Annual Scientific Meeting & Clinical Lab Expo. First held in 1949, this educational meeting and technology exposition is an event in the field of laboratory medicine, attracting an average of 20,000 participants.
=== Electron mass measurement === In practice, the atomic mass constant is determined from the electron rest mass me and the electron relative atomic mass Ar(e) (that is, the mass of electron divided by the atomic mass constant). The relative atomic mass of the electron can be measured in cyclotron experiments, while the rest mass of the electron can be derived from other physical constants.
The Hungarian Revolution of 1956 occurred shortly after Khrushchev arranged the removal of Hungary's Stalinist leader Mátyás Rákosi. In response to a popular anti-communist uprising, the new regime formally disbanded the secret police, declared its intention to withdraw from the Warsaw Pact and pledged to re-establish free elections. The Soviet Army invaded. Thousands of Hungarians were killed and arrested, imprisoned and deported to the Soviet Union, and approximately 200,000 Hungarians fled Hungary. Hungarian leader Imre Nagy and others were executed following secret trials. From 1957 through 1961, Khrushchev openly and repeatedly threatened the West with nuclear annihilation. He claimed that Soviet missile capabilities were far superior to those of the United States, capable of wiping out any American or European city. According to John Lewis Gaddis, Khrushchev rejected Stalin's "belief in the inevitability of war," however. The new leader declared his ultimate goal was "peaceful coexistence". In Khrushchev's formulation, peace would allow capitalism to collapse on its own, as well as giving the Soviets time to boost their military capabilities, which remained for decades until Gorbachev's later "new thinking" envisioning peaceful coexistence as an end in itself rather than a form of class struggle. The events in Hungary produced ideological fractures within the communist parties of the world, particularly in Western Europe, with great decline in membership, as many in both western and socialist countries felt disillusioned by the brutal Soviet response.
Awake – a short-lived artificial orange juice formulated by General Foods Corporation and introduced in 1964. It was a predecessor to Tang. Instant breakfast Chocolate drinks Hot chocolate Swiss Miss – hot chocolate Milo – can be prepared cold or hot Nesquik Ovaltine Instant coffee Drink mix Freeze-dried fruit juices Powdered milk – in a 1986 session in Moscow, Russia, the International Dairy Federation defined instant skim milk powder as qualifying for the term "instant" when no more than fifteen seconds are required for all lumps to disappear when the powder is mixed with water and stirred. Coconut milk powder Tang – a fruit-flavored drink that was originally formulated by General Foods Corporation food scientist William A. Mitchell in 1957. It was first marketed in powdered form in 1959. The Tang brand is owned by Mondelēz International. Instant tea Instant milk tea – a mass-produced instant powder
As early as 1971, Kardashev considered that this observation requires the preparation of a plan of listening and analysis, which will allow the success of the search for extraterrestrial civilizations. Humanity will then be able to solve the "main dilemma", as it was stated by Enrico Fermi. This dilemma is, according to the Soviet astronomer, is certainly connected with our lack of information and knowledge. Kardashev believes that a research project like Ozma is incapable of detecting a Type I civilization (an idea also promoted by Kaplan in 1971), and that SETI should instead focus on searching for intense radio signals that could emanate from active Type II or III civilizations. To prove the effectiveness of this approach, Kardashev therefore turned his attention to two radio sources discovered by the California Institute of Technology, nicknamed CTA-21 and CTA-102. Subsequently, Gennadii Borisovich Sholomitskii then used the Russian astronomical research station to study the data from CTA-102. He found that this radio source is characterized by its variability. Kardashev then considered that this could be an indication of an artificial emission source, albeit of rather short life span.
Sources: en.wikipedia.org
Note that virtually everything that happened in seasons 7-9 of Roseanne—other than Harris' birth—has been retconned out of existence in the show's universe, and there is no reason to assume that the date of Harris' birth is not affected by this retcon.
On September 30, 2009, the NNSA announced that about two thirds of the special nuclear material (e.g., plutonium) at LLNL requiring the highest level of security protection had been removed from LLNL. The move was part of NNSA's efforts initiated in October 2006 to consolidate special nuclear material at five sites by 2012, with significantly reduced square footage at those sites by 2017. The federally mandated project intended to improve security and reduce security costs, as part of NNSA's overall effort to transform the Cold War era "nuclear weapons" enterprise into a 21st-century "nuclear security" enterprise. The original date to remove all high-security nuclear material from LLNL, based on equipment capability and capacity, was 2014. NNSA and LLNL then developed a timeline to remove this material earlier, and accelerated the completion date to 2012.
As part of a major effort to address the ongoing economic crisis of the US, legislation was introduced to "reconstitute Project Socrates". The updated version of Socrates supports incubators by enabling users with technology-based facts about the marketplace, competitor maneuvers, potential partners, and technology paths to achieve competitive advantage. Michael Sekora, the original creator and director of Socrates says that a key purpose of Socrates is to assist government economic planners in addressing the economic and socioeconomic issues (see above) with unprecedented speed, efficiency and agility. Many for-profit or "private" incubation programs were launched in the late 1990s by investors and other for-profit operators seeking to hatch businesses quickly and bring in big payoffs. At the time, NBIA estimated that nearly 30% of all incubation programs were for-profit ventures. In the wake of the dot-com bust, however, many of those programs closed. In NBIA's 2002 State of the Business Incubation survey, only 16% of responding incubators were for-profit programs. By the 2006 SOI, just 6% of respondents were for-profit. Although some incubation programs (regardless of nonprofit or for-profit status) take equity in client companies, most do not. Only 25% of incubation programs report that they take equity in some or all of their clients.
=== Applications and operating systems === 1979: Apple II: VisiCalc (first spreadsheet program and killer app) 1979: CP/M systems: WordStar 1982: WordStar ported to CP/M-86 and IBM PC compatible/MS-DOS 1983: IBM PC compatible/MS-DOS: Lotus 1-2-3 (spreadsheet) 1985: Macintosh: Microsoft Excel (first WYSIWYG spreadsheet) and Microsoft Word (WYSIWYG word processor), Aldus (now Adobe) PageMaker (first desktop publishing program) 1985: AmigaOS: Deluxe Paint, Video Toaster, Prevue Guide 1987/1989: Microsoft Excel and Microsoft Word ported to Microsoft Windows 1993: Acorn Archimedes: Sibelius
Sources: en.wikipedia.org
=== Abuse of migrants === According to Human Rights Watch, Houthi militias have "beaten, raped, and tortured detained migrants and asylum seekers from the Horn of Africa." UN experts have warned that female migrants face sexual violence, forced labor, and forced drug trafficking by smugglers who collaborate with the Houthi-controlled Yemen Immigration, Passport and Nationality Authority (IPNA).
Jung identified two primary 'attitudinal types'—introvert and extrovert. While the terms 'introversion' and 'extraversion' had prior use in European thought, Jung was the first to integrate them into a comprehensive structural theory of personality. He redefined these concepts not merely as social traits, but as fundamental directions of psychic energy (libido), establishing the first systematic model of psychological types based on the movement of psychic energy libido toward the subject or the object. In Psychological Types, Jung defined the primary attitudinal types (introvert and extrovert), comparing them to the ancient archetypes: Apollo and Dionysus. The introvert is likened to Apollo, who shines a light on understanding. The introvert is focused on the internal world of reflection, dreaming, and vision. Thoughtful and insightful, the introvert can sometimes be uninterested in joining the activities of others. The introvert's libido flows inwards towards subjective factors and is influenced by 'inner necessity'. By contrast, the extravert is associated with Dionysus, interested in joining the activities of the world. The extravert is focused on the outside world of objects, sensory perception, and action. Energetic and lively, the extravert may lose their sense of self in the intoxication of Dionysian pursuits. For the extravert, the libido flows outwards, and the person has an interest, relationship and dependence on events, people and things. Jung's concepts of introversion and extraversion differ fundamentally from their common usage in modern trait psychology.
However, Casey withdrew from the event due to an undisclosed medical reason and was replaced by Gabriella Fernandes. On September 14, 2023, Casey had accepted a 4–month suspension by USADA after she reported herself in June 2023 for taking the prohibited substance BPC-157 to treat a medical condition. She is able to compete again as of October 1, 2023. On September 19, 2023, it was reported that Casey was removed from UFC roster.
Sources: en.wikipedia.org
It is a synthetic compound studied as an agonist of REV-ERB nuclear receptors. It is not an approved medicine and has mainly been examined in laboratory and animal research.
No. It is a small molecule that binds nuclear receptors involved in circadian regulation. Its classification differs from anabolic steroids or peptide hormones.
Published human clinical trial data are lacking. Most safety and activity information comes from preclinical models, so effects in people remain uncertain.
SR9009 is a synthetic research compound that acts on REV-ERB nuclear receptors. It is not approved for human use and is sold only as a research chemical. Its effects have been studied mainly in cells and rodents.